Toggle menu
  • sales@assaygenie.com
  • Select Currency: EUR
    • Euro
    • US Dollar
  • 25 Windsor Place Dublin 2 D02 VY42 Ireland
  • +353 15639720
  • Sign in Register
  • Compare
  • Cart
Assay Genie

Filter by Tag

  • Apoptosis
  • Cancer
  • Cell Signalling
  • Cellular Processes
  • COVID-19
  • Disease
  • Immunology
  • Interleukins
  • Microbiology
  • Neuroscience
  • PhD and Post Doc
  • Protocols
  • T cells
  • Therapeutics
  • Whitepaper
  • Home
  • Blog
  • therapeutics

Blog

Novel Gene Therapy for Cystic Fibrosis

Novel Gene Therapies for Cystic Fibrosis Cystic Fibrosis Cystic fibrosis (CF) is an autosomal recessive, life-limiting disease resulting from gene mutations that encode the cystic fibrosis transmembrane conductance regulator (CFTR). This gene is comprised of 27 exons and is located on chromosome 7. CFTR is a cAMP-regulated chloride channel located on the apical membrane of exocrine epithelial cells. CFTR is involved in regulating the epithelial sodium channel and bicarbonate transport. There are many different types of CFTR mutations that result in CF; lack of production; failure to reach the site of action; defects in gating; conductance; abnormally low channel numbers; and …
read more
6th Apr 2022 Laura O'Donoghue

Pyroptosis: A Promising Target for Immunotherapy

Pyroptosis is an immunogenic form of cell death, meaning that it triggers an immune response. This makes pyroptosis a potentially promising target for immunotherapies that aim to boost the immune system's response to cancer cells and other invaders. In this article, we will discuss pyroptosis in more detail, compare it to apoptosis and explore its potential as a therapeutic target. What is Pyroptosis ? Pyroptosis is a type of programmed cell death that occurs in response to infection or other cellular stresses. It is characterized by inflammatory cytokine release, membrane rupture, and cell lysis. Pyroptosis was first described in 2004 by Steinman and …
read more
22nd Mar 2022 Jahnavi Konduru Naga, Msc

PD-1 & PD-L1 Inhibitors

PD-1 & PD-L1 interaction between T-cells and tumour cells. What are PD-1 and PD-L1? PD-1, also known as programmed cell death 1, is a receptor expressed on the surface of T cells and plays a pivotal role in immune homeostasis, by keeping overstimulated responses at bay while safeguarding tissues from any unintended destruction. In essence, Programmed Cell Death Protein 1 (PD-1) keeps the body's immunity balanced. The ligands for PD-1 are programmed death-ligand 1 (PD-L1) and PD-L2, which are expressed on various cells including cancer cells, antigen-presenting cells, and non-immune cells. PD-1 and its ligands are powerful players in suppressing …
read more
21st Jan 2022 Rebecca Power MSc

Anti-CTLA-4 Immunotherapy

CD Markers Cluster of Differentiation (CD) markers play an important role in the differentiation of B cells, T cells and NK (natural killer) cells. These markers are often responsible for the identification of certain cancers and tumors, resulting in CD markers being good candidates for cancer therapies. CTLA-4 Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4)(CD152) is a protein receptor found on T cells. Both CTLA-4 and CD28 bind to B7-1/2 on antigen-presenting cells (APCs) such as dendritic cells and B cells. CTLA-4 has been shown to bind B7-1/2 with a higher affinity than CD28 d …
read more
11th Jan 2022 Fiona Redmond, PhD
Galectin Therapeutics

Galectin Therapeutics

Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis (IPF) is a chronic, irreversible and ultimately fatal disease characterized by progressive scaring (fibrosis) of the lungs. Affecting older adults, it targets the tissue between the lungs alveoli and the bloodstream, severely compromising gas exchange leading to worsening dyspnoea (difficulty breathing). It is associated with a poor prognosis, with several retrospective longitudinal studies suggesting a median survival of 2-3 years from the time of diagnosis (1). There is no known cause of IPF (thus the term “idiopathic” – a disease/condition which arises spo …
read more
27th Sep 2021 Dr. Duncan Humphries, Post-Doctoral Researcher at the University of Edinburgh
TLX as a Novel Therapeutic Target

TLX as a Novel Therapeutic Target

Danka Kozareva PhD Candidate, University College Cork The generation of neurons from stem cells The process of generating functional neurons from stem cells in the central nervous system (CNS) was believed to occur strictly during embryonic development and the early postnatal days in mammals (Ming and Song, 2011). A century ago this idea was challenged with the discovery of adult neurogenesis. Ezra Allen was the first to demonstrate that mitosis persisted in the lateral walls of adult albino rats (Allen, 1912). Several decades later Altman and Das (1965) followed up this research and determined that neurogenesis oc …
read more
1st Jan 1970 Danka Kozareva PhD Candidate, University College Cork
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Assay Genie
  • 25 Windsor Place
    Dublin 2
    D02 VY42
    Ireland
  • Call us at +353 15639720

Navigate

  • Services
  • Resources
  • Contact Us
  • Sitemap

International Websites

assaygenie.kr

assaygenie.jp

assaygenie.de

Categories

  • ELISA Kits
  • Multiplex ELISA
  • Cellular Assays
  • Antibodies
  • In Vivo Antibodies
  • Proteins

© Assay Genie.